Growth Hormone Research Peptides

This section groups growth hormone-axis research peptides: compounds that laboratories use to study the release, signalling and downstream effects of growth hormone (GH) in cell and animal models. CJC-1295 (no DAC) and Tesamorelin are analogues of growth hormone-releasing hormone (GHRH) that act at the GHRH receptor; Ipamorelin is a selective ghrelin-receptor (GHS-R) agonist, and the CJC-1295 + Ipamorelin blend combines the two pathways in one vial for studies that examine them together. AOD-9604 is a modified fragment of the GH molecule studied in lipid-metabolism research, IGF-1 LR3 is a long-acting analogue of insulin-like growth factor 1 used in cell-culture and receptor work, and DSIP (delta sleep-inducing peptide) is a neuropeptide listed here for laboratories studying sleep-related endocrine rhythms. The Ascend bundle groups several of these compounds in one order.

Vials are lyophilized and sealed, every batch is third-party tested, and lab reports are posted in the COA library. Our comparison pages, among them CJC-1295 vs Ipamorelin, Tesamorelin vs CJC-1295 and Ipamorelin vs Sermorelin, set the mechanisms side by side.

All growth-axis peptides are sold for laboratory research only. They are not for human or animal use, and no dosing or protocol information is provided.